Stock Code
688016.SH
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
Endovastec respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking "Save", only the cookies you selected will be used. You can with draw the consent that you granted here at any time by going to Cookies Settings. For more information, please see our Cookie Policy.
Stock Code
688016.SH
Senior Management
Mr. Zhu Qing, born in 1981, is a Chinese national with no permanent residency abroad and holds a Ph.D. in Biomedical Engineering from University of Shanghai for Science and Technology. Mr. Zhu served as R&D engineer of Shanghai Engineering Machinery Co., Ltd. from July 2003 to November 2003; successively as aortic intervention medical device R&D engineer, R&D head, R&D manager, and R&D director of MicroPort® from December 2003 to December 2014; vice president of R&D of Endovastec™ from January 2015 to June 2018; and deputy general manager of Endovastec™ in charge of R&D from July 2018 to August 2021. Since September 2021, he has been director and general manager of Endovastec™ and general manager of Intervastec™ .
Mr. Zhu Qing, born in 1981, is a Chinese national with no permanent residency abroad and holds a Ph.D. in Biomedical Engineering from University of Shanghai for Science and Technology. Mr. Zhu served as R&D engineer of Shanghai Engineering Machinery Co., Ltd. from July 2003 to November 2003; successively as aortic intervention medical device R&D engineer, R&D head, R&D manager, and R&D director of MicroPort® from December 2003 to December 2014; vice president of R&D of Endovastec™ from January 2015 to June 2018; and deputy general manager of Endovastec™ in charge of R&D from July 2018 to August 2021. Since September 2021, he has been director and general manager of Endovastec™ and general manager of Intervastec™ .
About us
News
Products
Investor Relations
Telephone:(86) (21) 38139300
Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China
Fax:(86) (21) 33750026
©Copyright 2002-2025, Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2024-0188
Website record/ license No.：沪ICP备14048493号-1 
HGWA Bei No.31011502014536
The registered trademarks of “微创", "MicroPort" and"
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
